Comis A, Easterbrook-Smith S B
Biochim Biophys Acta. 1986 Apr 22;870(3):426-31. doi: 10.1016/0167-4838(86)90250-5.
125I-labelled human C1q was found to bind to human spectrin. Scatchard plots for the binding process were non-linear, indicating the possible presence of multiple classes of binding sites for C1q on spectrin. The binding was ionic-strength-dependent; the extent of binding decreased with increasing ionic strength. Chemical modification of arginine and histidine residues on C1q as well as pretreatment of C1q at pH 4.45 or at 56 degrees C reduced its spectrin binding activity. The amount of 125I-labelled C1q bound to immune complexes was reduced by the presence of spectrin. Spectrin was also able to deplete the complement haemolytic activity of human serum in a dose-dependent manner.
发现125I标记的人C1q可与人血影蛋白结合。结合过程的Scatchard图呈非线性,表明血影蛋白上可能存在多类C1q结合位点。这种结合依赖于离子强度;随着离子强度增加,结合程度降低。对C1q上的精氨酸和组氨酸残基进行化学修饰,以及在pH 4.45或56℃对C1q进行预处理,均可降低其与血影蛋白的结合活性。血影蛋白的存在可减少与免疫复合物结合的125I标记C1q的量。血影蛋白还能够以剂量依赖的方式消耗人血清的补体溶血活性。